AURA 2023 includes data and analyses from 2020–2022 (primarily 2020–2021) from various sources and reports on patterns and trends in antimicrobial use and appropriateness and antimicrobial resistance (AMR) in Australian acute and community healthcare settings.
The Antimicrobial Use and Resistance in Australia (AURA) Surveillance System collects, reviews and analyses data on antimicrobial use and antimicrobial resistance in human health.
This complete version of the Opioid Analgesic Stewardship in Acute Pain Clinical Care Standard describes what each quality statement means for patients and their families, clinicians, and health service organisations, and provides indicators for local monitoring. It includes information about using clinical care standards, and the background and evidence sources for this standard.
This issue includes items on clinical quality registries, primary care, digital health and more. Along with the latest from BMJ Quality & Safety and The Joint Commission Journal on Quality and Patient Safety. Also included is the latest from the UK’s National Institute for Health and Care Excellence (NICE).
The Commission is seeking a full-time, ongoing EL2 Program Manager, Clinical Governance.
Information on this vacancy and how to apply can be found in the link below. Applications for this role will close 11.59pm Australian Eastern Daylight Time (AEDT), Wednesday 4 February 2026.
Questions about the role can be directed to Gillian Giles (02) 7232 5659.
This issue includes items on ‘corridor care’ or ‘temporary care environments’, pain and more. Along with the latest from BMJ Quality & Safety, American Journal of Medical Quality, BMJ Leader, Health Policy, Health Affairs JBI Evidence Synthesis and International Journal for Quality in Health Care. Also included is the latest from the UK’s National Institute for Health and Care Excellence (NICE) and the USA’s Agency for Healthcare Research and Quality (AHRQ)
The Commission is seeking your input to better understand the safety and quality risks and contemporary practice of the pathology sector.
Have your say on emerging safety and quality concerns and the required changes to the current edition of the Human Haemopoietic Progenitor Cells (HHPC) Standard (Sixth Edition 2021). The survey closes on 13 February 2026.
Australian Atlas of Healthcare Variation 2017: 3.4 Caesarean section data file.
The Commission is seeking a full-time, ongoing EL2 Manager, Medicines Safety and Quality.
Information on this vacancy and how to apply can be found in the link below. Applications for this role will close 11.59pm Australian Eastern Daylight Time (AEDT), Tuesday 27 January 2026.
Questions about the role can be directed to Sankit Lalseta (02) 7232 6225.